Differential DNA methylome profiling of nonfunctioning pituitary adenomas suggesting tumour invasion is correlated with cell adhesion

Gene expression profiling identifies ARSD as a new marker of disease progression and the sphingolipid metabolism as a potential novel metabolism in chronic lymphocytic leukemia

(2017) Alessandra Trojani et al.   Cancer Biomarkers

MANAGEMENT OF ENDOCRINE DISEASE: Clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies

(2014) Gerald Raverot et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Overexpression of the cell adhesion molecule claudin-9 is associated with invasion in pituitary oncocytomas

(2014) Lichuan Hong et al.   HUMAN PATHOLOGY

Epidemiology and etiopathogenesis of pituitary adenomas

(2014) Elena D. Aflorei et al.   JOURNAL OF NEURO-ONCOLOGY

A Pilot Genome-Scale Profiling of DNA Methylation in Sporadic Pituitary Macroadenomas: Association with Tumor Invasion and Histopathological Subtype

(2014) Chao Ling et al.   PLoS One

Diagnosis and management of prolactinomas and non-functioning pituitary adenomas

(2014) A. Rogers et al.   BMJ-British Medical Journal

A Composite Framework for the Statistical Analysis of Epidemiological DNA Methylation Data with the Infinium Human Methylation 450K BeadChip

(2014) Ioannis Valavanis et al.   IEEE Journal of Biomedical and Health Informatics

E-cadherin-integrin crosstalk in cancer invasion and metastasis

(2013) M. Canel et al.   JOURNAL OF CELL SCIENCE

The Role of Epigenetic Modification in Tumorigenesis and Progression of Pituitary Adenomas: A Systematic Review of the Literature

(2013) Matthew Pease et al.   PLoS One

GALNT9 Gene Expression Is a Prognostic Marker in Neuroblastoma Patients

(2012) N. Berois et al.   CLINICAL CHEMISTRY

Current treatment protocols can offer a normal or near-normal quality of life in the majority of patients with non-functioning pituitary adenomas

(2012) Cristina Capatina et al.   CLINICAL ENDOCRINOLOGY

Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas

(2012) Cuong V Duong et al.   ENDOCRINE-RELATED CANCER

The pituitary tumour epigenome: aberrations and prospects for targeted therapy

(2012) Kiren Yacqub-Usman et al.   Nature Reviews Endocrinology

Talin1 Promotes Tumor Invasion and Metastasis via Focal Adhesion Signaling and Anoikis Resistance

(2010) S. Sakamoto et al.   CANCER RESEARCH

Cancer Cells Cut Homophilic Cell Adhesion Molecules and Run

(2010) Sonya E.L. Craig et al.   CANCER RESEARCH

Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis

(2010) Françoise Galland et al.   ENDOCRINE-RELATED CANCER

MEMBRANOUS LAYERS OF THE PITUITARY GLAND

(2010) Qi Songtao et al.   Operative Neurosurgery

The Pathogenesis of Pituitary Tumors

(2009) Sylvia L. Asa et al.   Annual Review of Pathology-Mechanisms of Disease

Non-functioning pituitary adenomas

(2009) Yona Greenman et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Nuclear Accumulation of E-Cadherin Correlates with Loss of Cytoplasmic Membrane Staining and Invasion in Pituitary Adenomas

(2009) Marianne S. Elston et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pituitary tumours: all silent on the epigenetics front

(2009) K J Dudley et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas

(2008) Roger Gejman et al.   HUMAN PATHOLOGY